Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...
Safety and biomarker assessment of ST316, a novel peptide antagonist of ß-catenin, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Correlation of genetic variants and immunotherapy-combined modality with neoadjuvant therapy outcomes in microsatellite-stable rectal cancer. Prospective observational study of application of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results